Compare iShares MSCI Japan ETF (EWJ) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Japan ETF vs Stryker Corporation — how do they compare? iShares MSCI Japan ETF trades at $97.86 (market cap $23.87B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 4.5× iShares MSCI Japan ETF's market cap, and Stryker Corporation pays a 1.27% dividend while iShares MSCI Japan ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Japan ETF for 56 Days and Stryker Corporation for 21 Days on average.
| EWJ | SYK | |
|---|---|---|
Market Cap | $23.87B | $106.24B |
Volume | 5,412,820 | 2,982,001 |
Sector | Broad Market / Factor | Health |
52-Week High | $99.32 | $388.35 |
52-Week Low | $78.36 | $269.75 |
Typical Hold Time | 56 Days | 21 Days |
Enterprise Value | — | $117.70B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWJ, the iShares MSCI Japan ETF, trades at $97.32, down 1.02% on the day. Technical indicators show a neutral overall signal with mixed moving averages and oscillators. Recent news highlights Japan's monetary policy uncertainty as the Bank of Japan navigates rate hikes amid fiscal stimulus concerns. The ETF remains positioned within a tight trading range between $96 support and $99 resistance levels.
Outlook remains cautious as Japan faces monetary tightening headwinds while maintaining fiscal stimulus. Investment opportunity exists in Japan's AI and semiconductor exposure, though currency volatility and rising bond yields present near-term risks. The neutral technical stance suggests limited directional momentum pending clearer policy signals from Japanese authorities.
Stryker (SYK) trades at $276.97, up 0.57% today, amid a bearish technical signal with key support at $274 and resistance at $279. The company reported strong profitability with a 14.43% net income margin and beat Q2 2026 EPS estimates, though it missed in Q1. Recent news highlights ongoing legal scrutiny related to manufacturing issues disclosed in September 2026, which caused a significant share price drop.
Analyst consensus remains strongly bullish with a $368.11 price target, but risks include persistent manufacturing problems and potential securities litigation. Earnings growth and margin expansion support the long-term outlook, though near-term volatility may persist pending Q3 2026 results on October 29, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Japan ETF
EWJ tracks the MSCI Japan Index, providing broad exposure to over 180 large and mid-cap companies in Japan. It is the most established and liquid vehicle for accessing the Japanese equity market, featuring a diversified portfolio across industrials, consumer discretionary, and financial sectors.
Read more on EWJ →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
